1 year return (CAGR)
16.82%
Novavax Inc Exchange (NASDAQ, USD)
NVAX
10.55
+0.65 (+6.95%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
8.13%
5 year return (CAGR)
-47.83%
10 year return (CAGR)
-23.46%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.65B
Price/Sales
3.99
Ent value
2.60B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.62 |
| Daily high | 10.38 |
| Daily low | 9.61 |
| Daily Volume | 8.87M |
| All-time high | 319.93 |
| 1y analyst estimate | 14.00 |
| Beta | 2.42 |
| EPS (TTM) | -1.51 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NVAX | S&P500 | |
| Current price drop from All-time high | -96.70% | -1.29% |
| Highest price drop | -98.82% | -56.47% |
| Date of highest drop | 5 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -70.95% | -10.68% |
| Avg time to new high | 209 days | 12 days |
| Max time to new high | 4866 days | 1805 days |
News
